NCT04553562

Brief Summary

Chronic pelvic pain (CPP) is one of the common symptoms of women at childbearing age. The aim of this study is to assess the efficacy of acupuncture for female with non-cyclic chronic pelvic pain. A three-arm randomized controlled trial (RCT) using acupuncture, sham acupuncture and waiting list with a total sample of 150 will be conducted.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 17, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2022

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

November 23, 2021

Status Verified

November 1, 2021

Enrollment Period

10 months

First QC Date

September 6, 2020

Last Update Submit

November 20, 2021

Conditions

Keywords

AcupunctureSham acupunctureRandomized controlled trialNon-cyclic chronic pelvic pain

Outcome Measures

Primary Outcomes (1)

  • The change from baseline of the mean score in the past week of the Visual Analogue Scale

    The scores of the Visual Analogue Scale range from 0 to 10,higher scores mean a worse outcome.

    Week 6, 18 and 30

Secondary Outcomes (10)

  • The change from baseline of the Brief Pain Inventory score

    Week 6, 18 and 30

  • The change from baseline of the pain severity score of the Brief Pain Inventory

    Week 6, 18 and 30

  • The change from baseline of the pain interference score of the Brief Pain Inventory

    Week 6, 18 and 30

  • The proportion of patients with decrease of 0.6 score or more from baseline of the pain interference score of the Brief Pain Inventory

    Week 6, 18 and 30

  • The proportion of patients with decrease of 20% or more from baseline of the pain severity score of the Brief Pain Inventory

    Week 6, 18 and 30

  • +5 more secondary outcomes

Other Outcomes (4)

  • Blinding assessment

    Week 6

  • Safety assessment

    Week 0 to 30

  • Expectation of improvement assessment

    Baseline

  • +1 more other outcomes

Study Arms (3)

Acupuncture group

EXPERIMENTAL

For acupuncture group, sterile adhesive pads will be placed after skin disinfection on the acupoints. Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) will be inserted through the pads. The participants will be treated three times a week, on alternate days, for 6 successive weeks; 18 sessions for each patient in total.

Device: Acupuncture

Sham acupuncture group

SHAM COMPARATOR

For the sham acupuncture group, aterile adhesive pads will be placed after skin disinfection on the acupoints and needles with a blunt tip will be inserted at the same acupoints in the acupuncture group without penetrating the skin.No manipulation of needles will be conducted. The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.

Device: Sham acupuncture

Waiting list group

NO INTERVENTION

For the waiting list group, patients will receive no treatment in the first 6 weeks and will receive the same treatment used in the acupuncture group according to patients' preference.

Interventions

Sterile adhesive pads will be placed after skin disinfection on the acupoints. Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) will be inserted through the pads by the needles (0.30mm in diameter, 40 mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 25-30mm. Yintang (GV4) will be inserted through the pads by the needle (0.30mm in diameter, 25mm in length, Hwato Brand, Suzhou Medical Appliance Factory, China) to a depth of 10-15mm. The needles at all points will be lightly lifting, thrusting, and twirling every 10 minutes during each session with the sensation of sourness, achiness, heaviness and numbness (deqi). The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.

Acupuncture group

Sterile adhesive pads will be placed after skin disinfection on the acupoints. Needles (0.30 mm in diameter, 25 mm in length) with a blunt tip will be inserted at the Guanyuan (CV4),Qihai (CV6),bilateral Sanyinjiao (SP6), Yinbao (LR9), Qixue (KI13) and Fujie (SP14) without penetrating the skin. The participants will be treated three times a week, on alternate days (ideally), for 6 successive weeks; 18 sessions for each patient in total.

Sham acupuncture group

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Meet the diagnostic criteria of non-cyclic CPP.
  • Age 18 to 50 years.
  • Have moderate to severe pain in pelvis, anterior abdominal wall, lower back, or buttocks lasting at least six months.
  • The mean degree of pelvic pain in the past week rated by Visual Analogue Scale is ≥40 scores.
  • Sign informed consent and participate in the study voluntarily.

You may not qualify if:

  • Have endometriosis (including adenomyosis), ovarian cyst (larger than 3cm), hysteromyoma (larger than 3cm), severe pelvic adhesion, pelvic malignant tumor (relevant examination must be within the last 6 months).
  • Have acute pelvic/urinary tract infection.
  • Have pain after pelvic surgery.
  • Have recurrent gastrointestinal or bladder diseases such as irritable bowel syndrome, interstitial cystitis / bladder pain syndrome, etc.
  • During pregnancy or in lactation or have a pregnancy plan within 8 months.
  • Have heart, lung, liver, kidney, mental disorders or cognitive dysfunction.
  • Have acupuncture treatment in recent 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Zhishun Liu, PhD

    Guang'an men hospital, China Academy of Chinese Medical Sciences

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants in the acupuncture and sham acupuncture will be blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

September 6, 2020

First Posted

September 17, 2020

Study Start

December 1, 2021

Primary Completion

September 30, 2022

Study Completion

December 31, 2023

Last Updated

November 23, 2021

Record last verified: 2021-11